Sunshine Biopharma (SBFM) Net Income Growth (5y) (2016 - 2026)
Sunshine Biopharma (SBFM) Net Income Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Sunshine Biopharma | 750,608.81 | -6.16 Mn | 2.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.44% |
| Dec 31, 2024 | -44.88% |
| Jun 30, 2024 | -270.88% |
| Mar 31, 2024 | -260.38% |
| Dec 31, 2023 | -151.59% |
| Sep 30, 2023 | -163.75% |
| Jun 30, 2023 | -178.87% |
| Mar 31, 2023 | -47.70% |
| Dec 31, 2022 | -145.53% |
| Sep 30, 2022 | -59.48% |
| Jun 30, 2022 | -2.26% |
| Mar 31, 2022 | -59.94% |
| Dec 31, 2021 | 31.63% |
| Sep 30, 2021 | -99.40% |
| Jun 30, 2021 | -43.01% |
| Mar 31, 2021 | -140.65% |
| Jun 30, 2018 | 15.27% |
| Mar 31, 2018 | 23.57% |
| Dec 31, 2017 | 19.69% |
| Sep 30, 2017 | 17.84% |